Read the text below.
For the first time in more than a quarter-century, Americans have a new option when shopping for sunscreen: a skin-protecting chemical that’s long been a go-to option in Europe and other parts of the world. The U.S. Food and Drug Administration approved bemotrizinol — sometimes called BEMT — in June. The first sunscreens containing it are now hitting U.S. store shelves, including formulas from Neutrogena and other manufacturers. Dermatologists say the chemical fills an important market gap by offering broad protection, like the most well-established sunscreen ingredients, but without their cosmetic downsides, including white streaking. To be effective, sunscreens must protect against both forms of ultraviolet light that can damage the skin — UVB rays, which cause most sunburn, and UVA rays that pose the greatest risk of skin cancer and wrinkles.
Sunscreens that block both forms are labeled “broad spectrum protection.” Those that don’t must carry an FDA warning label. BEMT is the first chemical-based sunscreen in the U.S. that offers this dual protection. Previously, manufacturers had to mix multiple ingredients to protect against both UVA and UVB light. A different class of sunscreens, using minerals such as zinc oxide and titanium dioxide, has long been shown to offer strong protection against both forms of ultraviolet light. These mineral-based formulas work by physically blocking harmful rays from the skin. But some people — particularly those with darker complexions — tend to avoid them because they cause white streaking and discoloration. In other cases, people don’t like their texture or consistency.
As part of its safety review, the FDA reviewed studies of BEMT in more than 500 patients. Levels of the chemical absorbed into the skin were nearly undetectable, the studies found.
As with all sunscreens, dermatologists say it’s important to reapply every few hours — more frequently if you’re swimming or sweating a lot.
This article was provided by The Associated Press.